✦ LIBER ✦

Drug delivery trends in clinical trials and translational medicine

✍ Scribed by Jenny Y. Chien; Rodney J.Y. Ho

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 107 KB
Volume: 97
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.21426

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug delivery trends in clinical trials

Drug delivery trends in clinical trials and translational medicine: Updated analysis of ClinicalTrials.gov database

✍ Rodney J.Y. Ho; Jenny Y. Chien 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

While the number of clinical trials has continued to grow by about 20% in the past six months, no corresponding growth in product approval by the food and drug administration is seen or anticipated in the near future. Late-stage clinical failures due to lack of efficacy or toxicity continues to be a

Drug delivery trends in clinical trials

Drug delivery trends in clinical trials and translational medicine: Evaluation of pharmacokinetic properties in special populations

✍ Jenny Y. Chien; Rodney J.Y. Ho 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

In spite of the recent advances in technology to optimize the absorption, distribution, metabolism and elimination (ADME) properties of new and promising medicinal products to reduce clinical failures, the investigation of drug disposition in the pediatric and elderly populations continues to be und

Drug delivery trends in clinical trials

Drug delivery trends in clinical trials and translational medicine: Challenges and opportunities in the delivery of nucleic acid-based therapeutics

✍ Long Xu; Thomas Anchordoquy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

The ability to deliver nucleic acids (e.g., plasmid DNA, antisense oligonucleotides, siRNA) offers the potential to develop potent vaccines and novel therapeutics. However, nucleic acid-based therapeutics are still in their early stages as a new category of biologics. The efficacy of nucleic acids r

Trends and developments in liposome drug

Trends and developments in liposome drug delivery systems

✍ Tianshun Lian; Rodney J. Y. Ho 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Since the discovery of liposomes or lipid vesicles derived from self-forming enclosed lipid bilayers upon hydration, liposome drug delivery systems have played a signi®cant role in formulation of potent drugs to improve therapeutics. Currently, most of these liposome formulations are designed to red

Clinical involvement in anti-dementia dr

Clinical involvement in anti-dementia drug trials—why bother?

✍ Candida Graham; Clive Holmes; James Lindesay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

Finally, there must be realism. There will be limits to the funds available for expensive new drugs. Demand will always exceed resource. This realism must extend to our patients. We need to develop the skills to communicate our uncertainties and the dicult choices we face with our patients and the w

The NHLBI Clinical Trials Network in tra

The NHLBI Clinical Trials Network in transfusion medicine and hemostasis: An overview

✍ Walter H. Dzik 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract Transfusion Medicine is a broad discipline that affects the health care of patients from many medical disciplines. Despite the large impact of transfusion therapies on the management of patients with a variety of diseases, there are few clinical trials that evaluate the indications or t